| SOXS 1.79 4.07% | NVDA 177.19 -4.16% | ONMD 1.02 44.60% | NFLX 96.24 13.77% | JEM 0.096 3.90% | ENSC 0.6232 57.77% | BYND 0.9456 15.32% | PLUG 1.79 -6.28% | SOFI 17.76 -7.02% | NVD 7.53 8.50% | TZA 6.23 5.06% | NU 14.98 -0.53% | DUST 3.54 -3.50% | BITO 9.06 -2.78% | EOSE 5.695 -15.50% | XLF 51.43 -2.04% | BAC 49.83 -4.72% | AAL 13.07 -6.24% | MARA 8.94 5.80% | VEEA 0.5071 17.33% | SPY 685.99 -0.48% | SOXL 62.77 -3.93% | SLV 84.99 5.64% | XWEL 1.49 9.56% | QQQ 607.29 -0.32% | ONDS 10.08 -3.54% | BHAT 0.0495 -11.13% | PSKY 13.51 20.84% | INTC 45.61 0.33% | F 14.095 -2.19% | AAPL 264.18 -3.21% | XLE 55.92 1.58% | TQQQ 49.52 -1.06% | TSLA 402.51 -1.49% | HYG 80.72 -0.16% | TSDD 9.18 2.91% | TSLL 14.7 -3.10% | BATL 5.52 33.01% | RKT 18.19 2.36% | RXT 1.95 -14.47% | TLT 90.82 0.61% | TSLS 5.64 1.62% | WBD 28.17 -2.19% | PATH 10.73 0.14% | CRWV 79.56 -18.51% | IBIT 37.19 -2.80% | LQD 111.68 -0.04% | SOUN 8.6015 -4.21% | PLTR 137.19 0.92% | CPNG 19.08 1.98%

Solventum Corporation's Stock Performance and Analyst Ratings

Solventum Corporation, listed on the NYSE under the symbol SOLV, is a company that has recently caught the attention of investors and analysts. On January 25, 2026, KeyBanc upgraded Solventum's stock rating to "Overweight" from "Sector Weight," indicating a more optimistic view of the company's future performance. At the time of this upgrade, the stock was priced at $78.91.

Despite the positive outlook from KeyBanc, some institutional investors have adjusted their positions in Solventum. Anchor Capital Advisors LLC reduced its holdings by 2.2%, selling 13,376 shares. This leaves them with 597,911 shares, valued at $43.6 million, representing about 0.34% of Solventum's total shares. Meanwhile, Rakuten Investment Management Inc. acquired a new stake worth approximately $1.1 million.

Other investors have shown increased interest in Solventum. Universal Beteiligungs und Servicegesellschaft mbH increased its stake by 10.6% during the third quarter, now holding 56,069 shares valued at $4.1 million. This indicates a mixed sentiment among institutional investors, with some reducing and others increasing their stakes in the company.

Solventum has received varied recommendations from analysts. Out of fourteen brokerages, the stock has an average "Hold" rating. One analyst suggests "sell," eight recommend "hold," and five advise "buy." The average 12-month target price is $88.64. BTIG Research recently upgraded Solventum to a "buy" with a target price of $100, while Zacks Research downgraded it to a "hold."

Currently, NYSE:SOLV is trading at $78.91, reflecting a 1.68% decrease. The stock has fluctuated between $78.77 and $80.32 today. Over the past year, it reached a high of $88.20 and a low of $60.70. Solventum's market capitalization is approximately $13.69 billion, with a trading volume of 597,641 shares.

Published on: January 26, 2026